Reviewing Treatments for Cocaine Consume Problems: The Gabapentinoid Alternative

References

• National Center for Biotechnology Information. Pub chem substance database. Bethesda, USA: U.S. National Library of Medicine; December 1, 2016. Available from: https://pubchem.ncbi.nlm.nih.gov/substance/46506529D. Accessed January 5, 2018.
   Google Scholar
• Drug Information Portal. Search drug information portal. Bethesda, USA: U.S. National Library of Medicine; April 1, 2016. Available from: https://druginfo.nlm.nih.gov/drugportal/name/Gabapentin. Accessed January 5, 2018.
   Google Scholar
• Bockbrader HN, Wesche D, Miller R, Chapel S, Janiczek N, Burger P. A comparison of the pharmacokinetics and pharmacodynamics of pregabalin and gabapentin. Clin Pharmacokinet. 2010;49(10):661–669. doi:10.2165/11536200-000000000-00000
   PubMed Web of Science ®Google Scholar
• Hengy H, Kolle E-U. Determination of gabapentin in plasma and urine by high-performance liquid chromatography and pre-column labelling for ultraviolet detection. J Chromatogr. 1985;341(2):473–478. doi:10.1016/S0378-4347(00)84064-5
   Web of Science ®Google Scholar
• Reimann W. Inhibition by GABA, baclofen and gabapentin of dopamine release from rabbit caudate nucleus: are there common or different sites of action? Eur J Pharmacol. 1983;94(3–4):341–344. doi:10.1016/0014-2999(83)90425-9
   Web of Science ®Google Scholar
• Schlicker E, Reimann W, Gothert M. Gabapentin decreases monoamine release without affecting acetylcholine release in the brain. Arzneimittelforschung. 1985;35(9):1347–1349.
   Web of Science ®Google Scholar
• Vollmer KO, von Hodenberg A, Kolle EU. Pharmacokinetics and metabolism of gabapentin in rat, dog and man. Arzneimittelforschung. 1986;36(5):830–839.
   PubMed Web of Science ®Google Scholar
• Bartoszyk GD, Hamer M. The genetic animal model of reflex epilepsy in the Mongolian gerbil: differential efficacy of new anticonvulsive drugs and prototype antiepileptics. Pharmacol Res Commun. 1987;19(6):429–440. doi:10.1016/0031-6989(87)90082-8
   Google Scholar
• Crawford P, Ghadiali E, Lane R, Blumhardt L, Chadwick D. Gabapentin as an antiepileptic drug in man. J Neurol Neurosurg Psychiatry. 1987;50(6):682–686. doi:10.1136/jnnp.50.6.682
   PubMed Web of Science ®Google Scholar
• Ryback R, Ryback L. Gabapentin for behavioral dyscontrol. Am J Psychiatry. 1995;152(9):1399. doi:10.1176/ajp.152.9.1399a
   Web of Science ®Google Scholar
• Walden J, Hesslinger B. Value of old and new anticonvulsants in treatment of psychiatric diseases. Fortschr Neurol Psychiatr. 1995;63(8):320–335. doi:10.1055/s-2007-996633
   Web of Science ®Google Scholar
• Welty DF, Schielke GP, Rothstein JD. Potential treatment of amyotrophic lateral sclerosis with gabapentin: a hypothesis. Ann Pharmacother. 1995;29(11):1164–1167. doi:10.1177/106002809502901118
   Web of Science ®Google Scholar
• Rosner H, Rubin L, Kestenbaum A. Gabapentin adjunctive therapy in neuropathic pain states. Clin J Pain. 1996;12(1):56–58. doi:10.1097/00002508-199603000-00010
   Web of Science ®Google Scholar
• Shimoyama M, Shimoyama N, Inturrisi CE, Elliott KJ. Gabapentin enhances the antinociceptive effects of spinal morphine in the rat tail-flick test. Pain. 1997;72(3):375–382. doi:10.1016/s0304-3959(97)00065-1
   Web of Science ®Google Scholar
• Singh L, Field MJ, Ferris P, et al. The antiepileptic agent gabapentin (neurontin) possesses anxiolytic-like and antinociceptive actions that are reversed by D-serine. Psychopharmacology. 1996;127(1):1–9. doi:10.1007/bf02805968
   PubMed Web of Science ®Google Scholar
• Segal AZ, Rordorf G. Gabapentin as a novel treatment for postherpetic neuralgia. Neurology. 1996;46(4):1175–1176. doi:10.1212/wnl.46.4.1175
   Web of Science ®Google Scholar
• Adler CH. Treatment of restless legs syndrome with gabapentin. Clin Neuropharmacol. 1997;20(2):148–151. doi:10.1097/00002826-199704000-00006
   PubMed Web of Science ®Google Scholar
• Mellick GA, Mellick LB. Management of restless legs syndrome with gabapentin (neurontin). Sleep. 1996;19(3):224–226. doi:10.1093/sleep/19.3.224
   PubMed Web of Science ®Google Scholar
• Ryback RS, Brodsky L, Munasifi F. Gabapentin in bipolar disorder. J Neuropsychiatry Clin Neurosci. 1997;9(2):301. doi:10.1176/jnp.9.2.301b
   Web of Science ®Google Scholar
• Gass JT, Olive MF. Glutamatergic substrates of drug addiction and alcoholism. Biochem Pharmacol. 2008;75(1):218–265. doi:10.1016/j.bcp.2007.06.039
   PubMed Web of Science ®Google Scholar
• Minozzi S, Amato L, Davoli M, et al. Anticonvulsants for cocaine dependence. Cochrane Database Syst Rev. 2008;16(2):CD006754. doi:10.1002/14651858.CD006754.pub2
   Google Scholar
• Minozzi S, Cinquini M, Amato L, et al. Anticonvulsants for cocaine dependence. Cochrane Database Syst Rev. 2015;17(4):CD006754. doi:10.1002/14651858.CD006754.pub4
   Google Scholar
• Olive MF, Cleva RM, Kalivas PW, Malcolm RJ. Glutamatergic medications for the treatment of drug and behavioral addictions. Pharmacol Biochem Behav. 2012;100(4):801–810. doi:10.1016/j.pbb.2011.04.015
   PubMed Web of Science ®Google Scholar
• Zullino DF, Khazaal Y, Hättenschwiler J, Borgeat F, Besson J. Anticonvulsant drugs in the treatment of substance withdrawal. Drugs Today. 2004;40(7):603–619. doi:10.1358/dot.2004.40.7.850478
   PubMed Web of Science ®Google Scholar
• Berlin RK, Butler PM, Perloff MD. Gabapentin therapy in psychiatric disorders: a systematic review. Prim Care Companion CNS Disord. 2015;17(5). doi:10.4088/PCC.15r01821
   Google Scholar
• Howland RH. Gabapentin for the treatment of substance use disorders. J Psychosoc Nurs Ment Health Serv. 2013;51(12):11–14. doi:10.3928/02793695-20131120-01
   Web of Science ®Google Scholar
• Magnus L. Nonepileptic uses of gabapentin. Epilepsia. 1999;40(Suppl6):S66–S72; discussionS73-64. doi:10.1111/j.1528-1157.1999.tb00936.x
   PubMed Web of Science ®Google Scholar
• Myrick H, Henderson S, Brady KT, Malcolm R. Gabapentin in the treatment of cocaine dependence: a case series. J Clin Psychiatry. 2001;62(1):19–23. doi:10.4088/jcp.v62n0105
   PubMed Web of Science ®Google Scholar
• Raby WN, Coomaraswamy S. Gabapentin reduces cocaine use among addicts from a community clinic sample. J Clin Psychiatry. 2004;65(1):84–86. doi:10.4088/jcp.v65n0114
   PubMed Web of Science ®Google Scholar
• Hart CL, Haney M, Collins ED, Rubin E, Foltin RW. Smoked cocaine self-administration by humans is not reduced by large gabapentin maintenance doses. Drug Alcohol Depend. 2007;86(2–3):274–277. doi:10.1016/j.drugalcdep.2006.05.028
   Web of Science ®Google Scholar
• Hart CL, Haney M, Vosburg SK, Rubin E, Foltin RW. Gabapentin does not reduce smoked cocaine self-administration: employment of a novel self-administration procedure. Behav Pharmacol. 2007;18(1):71–75. doi:10.1097/FBP.0b013e328014139d
   PubMed Web of Science ®Google Scholar
• Hart CL, Ward AS, Collins ED, Haney M, Foltin RW. Gabapentin maintenance decreases smoked cocaine-related subjective effects, but not self-administration by humans. Drug Alcohol Depend. 2004;73(3):279–287. doi:10.1016/j.drugalcdep.2003.10.015
   Web of Science ®Google Scholar
• Bisaga A, Aharonovich E, Garawi F, et al. A randomized placebo-controlled trial of gabapentin for cocaine dependence. Drug Alcohol Depend. 2006;81(3):267–274. doi:10.1016/j.drugalcdep.2005.07.009
   PubMed Web of Science ®Google Scholar
• Berger SP, Winhusen TM, Somoza EC, et al. A medication screening trial evaluation of reserpine, gabapentin and lamotrigine pharmacotherapy of cocaine dependence. Addiction. 2005;100(Suppl1):58–67. doi:10.1111/j.1360-0443.2005.00983.x
   Google Scholar
• González G, Desai R, Sofuoglua M, et al. Clinical efficacy of gabapentin versus tiagabine for reducing cocaine use among cocaine dependent methadone-treated patients. Drug Alcohol Depend. 2007;87(1):1–9. doi:10.1016/j.drugalcdep.2006.07.003
   PubMed Web of Science ®Google Scholar
• Mancino MJ, McGaugh J, Chopra MP, et al. Clinical efficacy of sertraline alone and augmented with gabapentin in recently abstinent cocaine-dependent patients with depressive symptoms. J Clin Psychopharmacol. 2014;34(2):234–239. doi:10.1097/jcp.0000000000000062
   PubMed Web of Science ®Google Scholar
• Haney M, Hart C, Collins ED, Foltin RW. Smoked cocaine discrimination in humans: effects of gabapentin. Drug Alcohol Depend. 2005;80(1):53–61. doi:10.1016/j.drugalcdep.2005.03.006
   PubMed Web of Science ®Google Scholar
• Markowitz JS, Finkenbine R, Myrick H, Lunsford K, Carson WH. Gabapentin abuse in a cocaine user: implications for treatment? J Clin Psychopharmacol. 1997;17(5):423–424. doi:10.1097/00004714-199710000-00012
   PubMed Web of Science ®Google Scholar
• Raby WN. Gabapentin therapy for cocaine cravings. Am J Psychiatry. 2000;157(12):2058–2059. doi:10.1176/appi.ajp.157.12.2058-a
   Web of Science ®Google Scholar
• Spencer S, Brown RM, Quintero GC, et al. Alpha2delta-1 signaling in nucleus accumbens is necessary for cocaine-induced relapse. J Neurosci. 2014;34(25):8605–8611. doi:10.1523/jneurosci.1204-13.2014
   Web of Science ®Google Scholar
• Peng XQ, Li X, Li J, et al. Effects of gabapentin on cocaine self-administration, cocaine triggered relapse and cocaine-enhanced nucleus accumbens dopamine in rats. Drug Alcohol Depend. 2008;97(3):207–215. doi:10.1016/j.drugalcdep.2007.09.019
   Web of Science ®Google Scholar
• Filip M, Frankowska M, Zaniewska M, Gołda A, Przegaliński E, Vetulani J. Diverse effects of GABA-mimetic drugs on cocaine-evoked self-administration and discriminative stimulus effects in rats. Psychopharmacology. 2007;192(1):17–26. doi:10.1007/s00213-006-0694-7
   Web of Science ®Google Scholar
• Gasior M, Ungard JT, Witkin JM. Preclinical evaluation of newly approved and potential antiepileptic drugs against cocaine-induced seizures. J Pharmacol Exp Ther. 1999;290(3):1148–1156.
   Web of Science ®Google Scholar
• Chan B, Kondo K, Freeman M, Ayers C, Montgomery J, Kansagara D. Pharmacotherapy for cocaine use disorder—a systematic review and meta-analysis. J Gen Intern Med. 2019;34(12):2858–2873. doi:10.1007/s11606-019-05074-8
   PubMed Web of Science ®Google Scholar
• Saeed A, Ramya B, Padma K, et al. Use of gabapentin in the treatment of substance use and psychiatric disorders: a systematic review. Front Psychiatry. 2019;10:228. doi:10.3389/fpsyt.2019.00228
   Web of Science ®Google Scholar
• Richards JR, Le JK. Cocaine Toxicity. StatPearls. Treasure Island (FL): StatsPearls Publishing; 2020.
   Google Scholar